New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?

SLU Hospital is the first in Missouri to offer Cytalux, a 'glowing tumor' injection that helps surgeons see lung cancer ...

Among nearly 1,000 patients with lung cancer in a cohort study, only 35.1% met U.S. Preventive Services Task Force screening criteria. Universal age-based screening (40-85 years) detected 93.9% of ...

University of Texas MD Anderson Cancer Center researchers have discovered that YAP1 protein expression emerges after ...

A first-in-human clinical trial led by an international team of researchers and published in the New England Journal of Medicine found that setidegrasib, an investigational targeted therapy drug ...

Sensory neurons detect internal and external cues in organs and send this information to the brain. Lung cancer exploits this pathway to lessen immune responses. Read the paper: Tumour–brain crosstalk ...

Researchers have uncovered how proteins normally active only before birth can drive aggressive lung cancer, opening new avenues for future treatments. The study found that more aggressive lung cancers ...

Researchers at VIB and VUB have developed a powerful new way to study how the immune system behaves inside lung tumors. By combining a patient-relevant mouse model with single-cell technologies, the ...

A research team led by Dr. Juyeon Jung at the Bio-Nano Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), has developed a nanobody-based technology that can precisely ...

VIB-VUB researchers have developed a patient-relevant lung adenocarcinoma model combined with SEPARATE-Seq technology to ...